Infection and thrombosis resistant needle-free hemodialysis access port and graft using star biomaterials

Ended Project Grant Awarded Last action

Award ID
R44HL126256
Recipient
Awarding agency
Obligated
$8,249,857

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Funding
  • $7,265,385.00 Federal
  • $984,472.00 Non-federal
Place of performance
Seattle, WA 98103, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $984,472 $0
Amendment $984,472 $0
Amendment $984,472 $984,472
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $997,847 $0
Amendment $997,847 $0
Amendment Product and regulatory development of a needle-free hemodialysis access port $998,633 $0
Amendment $0 $0
Amendment $142,446 $0
Amendment $595,657 $0
Original award $579,539 $0
Show all 14

Quick answers

Who received award R44HL126256?

R44HL126256 was awarded to Healionics Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on April 1, 2015.

How much is award R44HL126256 worth?

$8,249,857 has been obligated on R44HL126256: $7,265,385 in federal funding and $984,472 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award